Britannia Industries

Similar documents
Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Britannia Industries

Mahindra & Mahindra. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

TVS Motors. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Bharat Petroleum Corporation

Thermax. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Source: Company Data; PL Research

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Bharat Electronics. Best defence play. Source: Company Data; PL Research

Dabur India. Source: Company Data; PL Research

Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research

Jindal Steel & Power

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Cadila Healthcare. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Dr. Lal PathLabs. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Indraprastha Gas. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Marico. Source: Company Data; PL Research

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Jindal Steel & Power

Glenmark Pharmaceuticals

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

Source: Company Data; PL Research

HDFC Standard Life Insurance

Tata Steel. Source: Company Data; PL Research

ICICI Prudential Life Insurance

Aurobindo Pharma. Source: Company Data; PL Research

NIIT Technologies. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Cig volumes surprise. Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

Punjab National Bank

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

Bayer Cropscience (BYRCS IN)

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

GMR Infrastructure. Airport revenues on a thaw, Power awaiting its turn. Q3FY13 Result Update

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Glenmark Pharmaceuticals

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

Pantaloon Retail India

NIIT Technologies. Source: Company Data; PL Research

Punjab National Bank

FY20E FY21E FY20E FY21E

Gujarat State Fertilisers & Chemicals

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

Mindtree. Source: Company Data; PL Research.

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

Punjab National Bank

Transcription:

Sustains momentum; Input cost gains peaked out November 09, 2015 Amnish Aggarwal amnishaggarwal@plindia.com +91 22 66322233 Gaurav Jogani gauravjogani@plindia.com +91 22 66322238 Rating Accumulate Price Rs3,130 Target Price Rs3,233 Implied Upside 3.3% Sensex 26,265 Nifty 7,954 (Prices as on November 06, 2015) Trading data Market Cap. (Rs bn) 374.3 Shares o/s (m) 119.6 3M Avg. Daily value (Rs m) 717.8 Major shareholders Promoters 50.74% Foreign 19.79% Domestic Inst. 8.83% Public & Other 20.64% Stock Performance (%) 1M 6M 12M Absolute (3.3) 4 105.9 Relative (0.8) 41.7 111.8 How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2016 65.6 68.5 4.2 2017 77.9 84.1 7.4 Price Performance (RIC: BRIT.BO, BB: BRIT IN) (Rs) 4,000 3,500 3,000 2,500 2,000 1,500 1,000 500 0 Nov 14 Jan 15 Source: Bloomberg Sep 15 Nov 15 BRIT s Q2 results are in line with sales growth of 11.9% and Adj. PAT of Rs2.03bn. Volume growth of ~11% looks impressive given slowdown in demand and shift of Diwali to 3QFY16. Strategic initiatives in distribution expansion, new mfg units and product restaging continued and should enable above industry average growth. We believe that input costs gains have peaked out as sugar prices are up 12% and Wheat 7% since 2QFY16. We estimate 320bps margin expansion and 31% PAT CAGR in standalone operations over FY15 18. We value the stock at 35xSept 17EPS given 41% ROE, 65% ROCE and 40% dividend payout. Maintain Accumulate. Gross margin at 41.7%; Adj. PAT up 28.9%: BRIT reported 11.9% increase in sales to Rs20.3bn; we estimate 11% (12% in Q1) volume growth, despite demand slowdown. Gross margins expanded 290bps to 42.2%. EBITDA margin expanded by 400bps to 14.9% as 100bps increase in advertising expenses (up 28%) and 30bps in staff cost (up 26%) were more than compensated by 130bps and 100bps savings in conversion cost and overheads. EBITDA increased 52.6%; PBT increased 63% aided by 62% higher other income and 18% lower depreciation. Adj PAT was up by 57.7% to Rs 2.03bn. Subsidiaries reported 12% higher sales but 14% decline in profit on higher spends on advertising, competition in dairy and economic turmoil in Middle East. Strategic initiatives in right direction: 1) Britannia sustained double digit volume growth despite slowdown in demand 2) New unit in Tamilnadu started production during the quarer 3) Britannia made reasonable inroads in northen region which aided growth 4) Britannia offred more valued to consumers in benign input cost environment by sales promotions 5) power brands of Goodday and Milk Bikis were restged. Input cost benefits have peaked: Input cost benefits have peaked as sugar prices are up 12% since 2Q and are up 21% from bottom. Wheat prices are up 7% since 2Q end and are likely to remain firm till new crop in march. Palmoil and SMP prices are down 21% and 43% on YoY basis. Key financials (Y/e March) 2014 2015 2016E 2017E Revenues (Rs m) 63,074 71,760 81,617 96,232 Growth (%) 12.3 13.8 13.7 17.9 EBITDA (Rs m) 5,966 7,715 11,463 13,629 PAT (Rs m) 3,898 5,097 7,863 9,347 EPS (Rs) 32.5 42.5 65.6 77.9 Growth (%) 66.1 30.8 54.3 18.9 Net DPS (Rs) 12.0 16.0 21.0 27.0 Profitability & Valuation 2014 2015 2016E 2017E EBITDA margin (%) 9.5 10.8 14.2 RoE (%) 51.9 48.6 53.2 47.0 RoCE (%) 44.1 48.2 52.7 46.7 EV / sales (x) 5.9 5.1 4.5 3.7 EV / EBITDA (x) 62.4 47.4 31.8 26.4 PE (x) 96.3 73.7 47.7 40.2 P / BV (x) 43.8 30.3 21.8 16.6 Net dividend yield (%) 0.4 0.5 0.7 0.9 Source: Company Data; PL Research Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

Exhibit 1: Result Overview (Rs m); 57.7% Adj. PAT growth as EBITDA margins expands 400bps Y/e March YoY gr. (%) H1FY16 HFY15 YoY gr. (%) Net Sales 20,329 18,174 11.9 18,471 38,800 34,516 12.4 Gross Profit 8,585 7,147 20.1 7,729 16,315 13,456 21.2 Margins (%) 42.2 39.3 41.8 42.0 39.0 Other Exp 5,562 5,165 7.7 5,135 10,696 9,897 8.1 % of Sales 27.4 28.4 27.8 27.6 28.7 EBITDA 3,024 1,982 52.6 2,595 5,619 3,560 57.8 Margins (%) 14.9 10.9 14.5 10.3 Depreciation 206 251 (17.9) 209 415 497 (16.5) Interest 3 4 (14.3) 3 6 6 (4.8) Other Income 300 185 62.0 183 483 381 26.7 PBT 3,115 1,913 62.9 2,566 5,681 3,438 65.2 Tax 1,078 621 73.6 888 1,966 1,068 84.1 Tax Rate (%) 34.6 32.5 34.6 34.6 31.1 Adjusted PAT 2,037 1,292 57.7 1,678 3,715 2,370 56.7 Extraordinary (Income) 1,239 1,239 Reported PAT 2,037 2,530 (19.5) 1,678 3,715 3,609 2.9 Exhibit 2: Volume growth sustained in double digit at 11% Exhibit 3: Sales impacted by 100bps excise phase out impact 12.0 8.0 6.0 4.0 2.0 6.0 6.0 4.5 3.0 7.5 9.0 9.0 12.0 11.0 16.0 15.0 13.0 12.0 11.0 9.0 8.0 13.7 11.1 9.0 15.3 13.0 13.6 13.0 11.9 1QFY14 2QFY14 3QFY14 4QFY14 Q2FY14 Q3FY14 Q4FY14 November 09, 2015 2

Exhibit 4: Gross margins expanded 290bps due to benign input costs Gross Margins have expanded by 290bps, while EBITDA margins have expanded 400bps 45.0 4 35.0 3 25.0 Gross Margins (%) Overheads (%) EBIDTA Margins (%) 4 39.3 9.5 30.4 Q2FY14 Q3FY14 Q4FY14 10.8 42.2 14.9 28.5 27.4 16.0 12.0 8.0 6.0 4.0 2.0 Conversion cost and overheads enable higher margin expansion despite 28% higher adspend and 26% higher staff costs Exhibit 5: Adspend up 100bps, overheads and conversion cost down 100bps and 130bps Ad Spend Conversion Cost Other expenses 3 25.0 2 15.0 5.0 10.8 10.5 11.1 10.8 10.6 10.4 10.4 9.8 9.6 8.9 9.0 8.2 8.2 8.7 8.7 7.9 7.9 7.5 8.2 8.1 6.8 7.2 6.8 7.6 9.1 7.3 7.8 Q2FY14 Q3FY14 Q4FY14 Exhibit 6: Growth in Bread, Cakes and Rusk higher than biscuits Biscuits Bread, cake and Rusk 35.0 3 25.0 2 15.0 5.0 22.6 23.1 26.2 29.8 6.9 16.3 11.5 19.8 13.7 6.1 13.9 17.8 12.7 20.4 17.2 21.5 FY10 FY11 FY12 FY13 FY14 FY15 FY16E FY17E November 09, 2015 3

Exhibit 7: Palm Oil Prices down 21% YoY and 12.8% QoQ Palm Oil Prices (17% of the total raw material cost) are quoting at 6 year lows 60,000 55,000 54,243 50,000 45,000 40,000 35,000 30,000 46,905 37,000 39,745 34,719 32,518 25,000 28,230 May 13 Jul 13 Sep 13 Nov 13 Jan 14 Mar 14 May 14 Jul 14 Sep 14 Nov 14 Jan 15 Sep 15 Nov 15 (Rs/MT) Source: Bloomberg, PL Research Wheat (27% of raw materials) prices are up Exhibit 8: Wheat Prices up 0.4% YoY and 4.1% QoQ in 7% since 2Q, unlikely to decline before March 2016s 1,800 1,700 1,661 1,670 1,690 (Rs / Quintal) 1,600 1,500 1,400 1,510 1,542 1,300 1,200 Sep 13 Oct 13 Nov 13 Dec 13 Jan 14 Feb 14 Mar 14 Apr 14 May 14 Jun 14 Jul 14 Aug 14 Sep 14 Oct 14 Nov 14 Dec 14 Jan 15 Feb 15 Apr 15 Jun 15 Aug 15 Sep 15 Oct 15 Source: Bloomberg, PL Research Sugar prices are up 21% from the lows of Rs 2360/MT and 12% since 2Q Exhibit 9: Sugar Prices down 23.2% YoY & 3.4% QoQ in (Rs / MT) 3,600 3,415 3,400 3,370 3,200 3,000 2,865 2,870 2,975 2,800 2,745 2,600 2,400 2,360 2,200 Mar 13 Apr 13 Jun 13 Aug 13 Sep 13 Nov 13 Jan 14 Feb 14 Apr 14 Jun 14 Jul 14 Sep 14 Oct 14 Dec 14 Feb 15 Aug 15 Oct 15 Source: Bloomberg, PL Research November 09, 2015 4

Income Statement (Rs m) Net Revenue 63,074 71,760 81,617 96,232 Raw Material Expenses 43,523 49,187 53,994 64,011 Gross Profit 19,551 22,573 27,622 32,221 Employee Cost 1,725 1,768 2,020 2,336 Other Expenses 11,861 13,090 14,140 16,256 EBITDA 5,966 7,715 11,463 13,629 Depr. & Amortization 634 1,173 916 1,194 Net Interest (294) (863) (1,190) (1,411) Other Income 348 875 1,202 1,424 Profit before Tax 5,626 7,405 11,736 13,847 Total Tax 1,728 2,309 3,873 4,500 Profit after Tax 3,898 5,097 7,863 9,347 Ex Od items / Min. Int. (400) 2,254 Adj. PAT 3,898 5,097 7,863 9,347 Avg. Shares O/S (m) 12 12 12 12 EPS (Rs.) 32.5 42.5 65.6 77.9 Cash Flow Abstract (Rs m) C/F from Operations 7,172 8,322 9,167 11,578 C/F from Investing 2,491 8,131 5,935 7,671 C/F from Financing (4,687) (481) (3,078) (19,244) Inc. / Dec. in Cash 4,976 15,972 12,024 5 Opening Cash 645 640 349 503 Closing Cash 639 349 503 508 FCFF 5,666 7,963 4,651 9,175 FCFE 2,957 8,046 4,645 9,175 Key Financial Metrics Growth Revenue (%) 12.3 13.8 13.7 17.9 EBITDA (%) 60.6 29.3 48.6 18.9 PAT (%) 66.7 30.8 54.3 18.9 EPS (%) 66.1 30.8 54.3 18.9 Profitability EBITDA Margin (%) 9.5 10.8 14.2 PAT Margin (%) 6.2 7.1 9.6 9.7 RoCE (%) 44.1 48.2 52.7 46.7 RoE (%) 51.9 48.6 53.2 47.0 Balance Sheet Net Debt : Equity (0.3) (0.8) (0.6) (0.7) Net Wrkng Cap. (days) (7) (16) (14) (14) Valuation PER (x) 96.3 73.7 47.7 40.2 P / B (x) 43.8 30.3 21.8 16.6 EV / EBITDA (x) 62.4 47.4 31.8 26.4 EV / Sales (x) 5.9 5.1 4.5 3.7 Earnings Quality Eff. Tax Rate 30.7 31.2 33.0 32.5 Other Inc / PBT 6.2 11.8 10.2 10.3 Eff. Depr. Rate (%) 6.7 11.7 6.2 6.8 FCFE / PAT 75.9 157.9 59.1 98.2. Balance Sheet Abstract (Rs m) Shareholder's Funds 8,577 12,392 17,184 22,628 Total Debt 56 139 133 133 Other Liabilities Total Liabilities 8,633 12,531 17,317 22,761 Net Fixed Assets 6,429 5,742 9,543 11,149 Goodwill Investments 1,845 1,904 1,904 1,904 Net Current Assets 451 4,675 5,424 8,916 Cash & Equivalents 3,043 9,573 10,945 15,820 Other Current Assets 7,128 7,190 8,421 9,882 Current Liabilities 9,720 12,089 13,942 16,787 Other Assets (92) 211 446 792 Total Assets 8,633 12,531 17,317 22,761 Quarterly Financials (Rs m) Y/e March Net Revenue 18,523 18,720 18,471 20,329 EBITDA 1,942 2,212 2,595 3,024 % of revenue 10.5 11.8 14.9 Depr. & Amortization 255 421 209 206 Net Interest 3 3 3 3 Other Income 205 290 183 300 Profit before Tax 1,889 2,079 2,566 3,115 Total Tax 599 641 888 1,078 Profit after Tax 1,205 1,410 1,678 2,037 Adj. PAT 1,290 1,437 1,678 2,037. November 09, 2015 5

Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai 400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage 50% 40% 30% 20% 10% 0% 44.7% 43.7% 11.7% % BUY Accumulate Reduce Sell BUY : Over 15% Outperformance to Sensex over 12 months Accumulate : Outperformance to Sensex over 12 months Reduce : Underperformance to Sensex over 12 months Sell : Over 15% underperformance to Sensex over 12 months Trading Buy : Over 10% absolute upside in 1 month Trading Sell : Over 10% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Amnish Aggarwal (MBA, CFA), Mr. Gaurav Jogani (MBA, Bcom), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Amnish Aggarwal (MBA, CFA), Mr. Gaurav Jogani (MBA, Bcom), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. November 09, 2015 6